SE463263B - Foerfarande foer framstaellning av kristallin cefuroxim-1-acetoxietylester - Google Patents

Foerfarande foer framstaellning av kristallin cefuroxim-1-acetoxietylester

Info

Publication number
SE463263B
SE463263B SE8403897A SE8403897A SE463263B SE 463263 B SE463263 B SE 463263B SE 8403897 A SE8403897 A SE 8403897A SE 8403897 A SE8403897 A SE 8403897A SE 463263 B SE463263 B SE 463263B
Authority
SE
Sweden
Prior art keywords
cefuroxime
crystalline
minutes
stirred
process according
Prior art date
Application number
SE8403897A
Other languages
English (en)
Swedish (sv)
Other versions
SE8403897D0 (sv
SE8403897L (sv
Inventor
H A Crisp
M Wright
J P Turnbull
J F Oughton
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of SE8403897D0 publication Critical patent/SE8403897D0/xx
Publication of SE8403897L publication Critical patent/SE8403897L/
Publication of SE463263B publication Critical patent/SE463263B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8403897A 1983-07-29 1984-07-27 Foerfarande foer framstaellning av kristallin cefuroxim-1-acetoxietylester SE463263B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838320521A GB8320521D0 (en) 1983-07-29 1983-07-29 Chemical process

Publications (3)

Publication Number Publication Date
SE8403897D0 SE8403897D0 (sv) 1984-07-27
SE8403897L SE8403897L (sv) 1985-01-30
SE463263B true SE463263B (sv) 1990-10-29

Family

ID=10546505

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8403897A SE463263B (sv) 1983-07-29 1984-07-27 Foerfarande foer framstaellning av kristallin cefuroxim-1-acetoxietylester

Country Status (21)

Country Link
JP (1) JPH0613526B2 (fr)
KR (1) KR910008377B1 (fr)
AT (1) AT392470B (fr)
AU (2) AU582121B2 (fr)
BE (1) BE900241A (fr)
CA (1) CA1265511A (fr)
CH (1) CH662121A5 (fr)
DE (1) DE3427828A1 (fr)
DK (1) DK165505C (fr)
ES (1) ES8601869A1 (fr)
FI (1) FI76808C (fr)
FR (1) FR2549837B1 (fr)
GB (2) GB8320521D0 (fr)
IE (1) IE57726B1 (fr)
IL (1) IL72536A (fr)
NL (1) NL8402372A (fr)
NO (1) NO167292C (fr)
NZ (1) NZ209046A (fr)
PT (1) PT78985B (fr)
SE (1) SE463263B (fr)
ZA (1) ZA845830B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8400024D0 (en) * 1984-01-03 1984-02-08 Glaxo Group Ltd Cephalosporin antibiotics
GB8524001D0 (en) * 1985-09-30 1985-11-06 Glaxo Group Ltd Pharmaceutical composition
US5063224A (en) * 1990-07-09 1991-11-05 Eli Lilly And Company R-cefuroxime axetil
IT1277426B1 (it) * 1995-08-03 1997-11-10 Acs Dobfar Spa Forma cristallina biodisponibile del cefuroxima axetil
CN1111537C (zh) * 1997-05-15 2003-06-18 第一制糖株式会社 高纯晶形头孢呋辛1－乙酰氧乙酯的制备方法
KR100228264B1 (ko) * 1997-08-02 1999-11-01 김선진 결정형 세푸록심 악세틸의 제조방법
CA2209868C (fr) * 1997-08-15 2001-08-14 Bernard Charles Sherman Compositions pharmaceutiques a base de cefuroxime axetil
IN186539B (fr) * 1997-09-29 2001-09-29 Ranbaxy Lab Ltd
ATE212638T1 (de) * 1998-02-20 2002-02-15 Fako Ilaclari A S Verfahren zur herstellung vom löslichen kristallinen cefuroxim axetil
IN190849B (fr) 2000-07-17 2003-08-23 Ranbaxy Lab Ltd
AT411996B (de) 2000-09-11 2004-08-26 Sandoz Ag Verfahren zur herstellung von cefuroxim in der form seines n-butylammoniumsalzes
ITMI20011763A1 (it) * 2001-08-10 2003-02-10 Antibioticos Spa Processo di preparazione di cefuroxime axelite ad elevata purezza
ITMI20011925A1 (it) * 2001-09-14 2003-03-14 Antibioticos Spa Metodo applicabile su scala industriale per la preparazione di cefuroxime axetile cristallino
TWI328006B (en) * 2003-12-26 2010-08-01 Nissan Chemical Ind Ltd Crystal form of quinoline compound and process for its production
CN100448879C (zh) * 2004-07-22 2009-01-07 北京化工大学 一种无定型头孢呋辛酯的制备方法
DE102005019458A1 (de) 2005-04-25 2006-10-26 Grünenthal GmbH Darreichungsform mit verbesserter Freisetzung von Cefuroximaxetil

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1094545A (fr) * 1976-02-16 1981-01-27 Michael Gregson Traduction non-disponible
GB1571683A (en) * 1976-02-16 1980-07-16 Glaxo Operations Ltd Ester derivatives of cefuroxime
GB1598568A (en) * 1977-04-19 1981-09-23 Glaxo Lab Ltd Esters of(6r,7r)-3-carbamoyloxymethyl-7-((z)-2-(fur-2-yl)-2-methoxyiminoacetamido)-ceph-3-em-4-carboxylic acid
JPS577485A (en) * 1980-06-13 1982-01-14 Takeda Chem Ind Ltd Cephalosporin
YU44680B (en) * 1982-07-30 1990-12-31 Glaxo Lab Ltd Process for obtaining very pure amorphous form of cephuroxim axetile
GB8400024D0 (en) * 1984-01-03 1984-02-08 Glaxo Group Ltd Cephalosporin antibiotics

Also Published As

Publication number Publication date
FI76808B (fi) 1988-08-31
NZ209046A (en) 1988-02-29
AU3125684A (en) 1985-01-31
GB2145409A (en) 1985-03-27
BE900241A (fr) 1985-01-28
DK366684D0 (da) 1984-07-27
ZA845830B (en) 1986-03-26
ATA244484A (de) 1990-09-15
ES534695A0 (es) 1985-11-01
PT78985A (en) 1984-08-01
GB2145409B (en) 1987-02-18
GB8419202D0 (en) 1984-08-30
NO843055L (no) 1985-01-30
DE3427828A1 (de) 1985-02-14
FR2549837B1 (fr) 1986-12-26
FR2549837A1 (fr) 1985-02-01
IL72536A (en) 1988-01-31
AU3660189A (en) 1989-10-05
JPH0613526B2 (ja) 1994-02-23
DK165505B (da) 1992-12-07
SE8403897D0 (sv) 1984-07-27
DK165505C (da) 1993-04-19
GB8320521D0 (en) 1983-09-01
AU582121B2 (en) 1989-03-16
AT392470B (de) 1991-04-10
FI843011A0 (fi) 1984-07-27
PT78985B (en) 1986-10-23
JPS6075484A (ja) 1985-04-27
FI843011A (fi) 1985-01-30
SE8403897L (sv) 1985-01-30
ES8601869A1 (es) 1985-11-01
IE841938L (en) 1985-01-29
KR910008377B1 (ko) 1991-10-12
FI76808C (fi) 1988-12-12
KR850001221A (ko) 1985-03-16
DK366684A (da) 1985-01-30
NO167292B (no) 1991-07-15
AU634965B2 (en) 1993-03-11
NO167292C (no) 1991-10-23
NL8402372A (nl) 1985-02-18
IL72536A0 (en) 1984-11-30
CH662121A5 (de) 1987-09-15
IE57726B1 (en) 1993-03-24
CA1265511A (fr) 1990-02-06

Similar Documents

Publication Publication Date Title
SE463263B (sv) Foerfarande foer framstaellning av kristallin cefuroxim-1-acetoxietylester
WO2004046154A1 (fr) Nouvel hydrate amorphe d'une cephalosporine
EP1458728A1 (fr) Dihydrate de cefdinir potassium cristallin
US4222942A (en) Isolation of organic acids
AU659282B2 (en) Process for the production of pharmaceutically acceptable salts of clavulanic acid
SU541438A3 (ru) Способ получени ацилуреидоцефалоспоринов или их солей или эфиров
US20150119570A1 (en) Process of preparing alcaftadine
JPS626718B2 (fr)
SU1405704A3 (ru) Способ получени метилендиолдикарбоксилатных соединений или их фармацевтически приемлемых щелочных или четвертичных аммониевых солей
IL106388A (en) Process for preparing intermediates for cephalosporins
US4064137A (en) Penicillin and cephalosporin derivatives and process for preparing the same
US4959495A (en) Process for the preparation of intermediates used to produce aminothiazoloximino cephalosporins
US5149873A (en) Process for the purification of mandelic acid N,N-diethylamide
KR960015966B1 (ko) 결정상 항생제 중간물질
KR100423890B1 (ko) 세팔로스포린 유도체의 새로운 제조방법
JPH0780890B2 (ja) ６−〔Ｄ（−）−α−（４−エチル−２，３−ジオキソピペラジン−１−イルカルボニルアミノ）−α−フェニルアセトアミド〕−ペニシラン酸の製法
US4048158A (en) d-α-Isobutylsulfobenzylpenicillin hemi-solvate crystals
GB2039900A (en) Octahydro-indolo[2,3- a]quinolisine derivative
HU195798B (en) Process for producing benzofuranyl-carbamate derivatives
KR20040097930A (ko) Ｎ-메틸-ｎ-페닐아미노아크롤레인의 합성 방법
HU183983B (en) Process for preparing brominated hydroxyimino-e-homo-eburnan derivatives
HU184748B (en) Process for preparing phenyl-glycyl-chloride-hydrochloride
JPH0141151B2 (fr)
KR19980035249A (ko) 세팔로스포린 유도체의 에스테르 제조방법
NO822870L (no) Prosess for produksjon av penicillin- og cephalosporinderivater

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8403897-5

Format of ref document f/p: F

NUG Patent has lapsed